{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Sugar Land",
      "address_1": "1075 W Park One Dr Suite 200",
      "reason_for_recall": "Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it  because fliptop vial crimps were loose or missing.",
      "address_2": "",
      "product_quantity": "12 bags",
      "code_info": "Lot 7250-0 Exp. 08/14",
      "center_classification_date": "20140821",
      "distribution_pattern": "Texas and Georgia",
      "state": "TX",
      "product_description": "fentaNYL 200 mcg/100 mL (2 mcg/mL) and Ropivacaine 0.2% in 0.9% Sodium Chloride 100mL, in flexable bag,  COMPOUNDED DRUG   For Institutional or Office Use Only--Not for Resale   Federal Law Prohibits Dispensing without Prescription  Healix Infusion Therapy, Inc., at 866-299-4826, 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478, NDC 75901-8007-02",
      "report_date": "20140827",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Healix Infusion Therapy, Inc.",
      "recall_number": "D-1553-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "69056",
      "termination_date": "20150825",
      "more_code_info": "",
      "recall_initiation_date": "20140627",
      "postal_code": "77478-2576",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}